←Back to Expert Scholars
Translational Medicine / 转化医学Cancer PRO, Patient Reported Outcomes
Fabio Efficace
PhD
🏢Italian Group for Adult Hematologic Diseases (GIMEMA)🌐Italy
Head, Health Outcomes Research Unit
55
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Fabio Efficace leads PRO research in hematologic malignancies through GIMEMA and contributes to EORTC Quality of Life Group initiatives. His work has defined PRO endpoints for CML, MDS, and acute leukemia trials. He has contributed to international PRO measurement standards in hematology.
Share:
🧪Research Fields 研究领域
patient reported outcomes
hematologic malignancies
quality of life
EORTC QLQ-C30
PRO methodology
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Fabio Efficace 的研究动态
Follow Fabio Efficace's research updates
留下邮箱，当我们发布与 Fabio Efficace（Italian Group for Adult Hematologic Diseases (GIMEMA)）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment